|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Investment income | |||||
| Interest expense | |||||
| Loss before provision for income taxes | |||||
| Income tax provision | |||||
| Net loss and comprehensive loss | |||||
| Net loss per share, basic (USD per share) | |||||
| Net loss per share, diluted (USD per share) | |||||
| Weighted-average shares of Class A common stock outstanding – basic (in shares) | |||||
| Weighted average Class A common shares outstanding, diluted (in shares) | |||||
Loading...
